Phi Life Sciences is a Charleston-based molecular diagnostic and laboratory services company that aims to reduce disease mortality and adverse drug reactions through affordable, state-of-the-art screening and diagnostic technologies. The company emphasizes a bench-to-bedside approach, providing doctors and patients with cutting-edge screening and diagnostic tools to detect diseases at the earliest stages for more effective treatment. Its laboratory is accredited by CLIA and CAP and is located at the SCRA MUSC Innovation Center in Charleston, South Carolina. Phi Life Sciences has been an SC Launch client company since 2016 and says it seeks to be a leader in growing the biotech industry in South Carolina. The company has received support from SCRA’s SC Launch program to advance its commercial and clinical reach. The article does not disclose revenue, user metrics, or prior funding amounts beyond the recent SC Launch investment.

Total raised

$0M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2017